Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1116

1.

Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.

Jiménez BC, Navarro M, Huerga H, López-Román E, Mendoza A, López-Vélez R.

J Travel Med. 2006 Nov-Dec;13(6):373-5.

2.

Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.

Gallien S, Taieb F, Schlemmer F, Lagrange-Xelot M, Atlan A, Sarfati C, Molina JM.

Travel Med Infect Dis. 2008 May;6(3):128-9. doi: 10.1016/j.tmaid.2008.01.011. Epub 2008 Apr 2.

PMID:
18486067
3.

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.

Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL; Naval Medical Research Unit 2 Clinical Trial Team.

Clin Infect Dis. 2002 Oct 1;35(7):825-33. Epub 2002 Sep 11.

PMID:
12228819
5.

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.

Lacy MD, Maguire JD, Barcus MJ, Ling J, Bangs MJ, Gramzinski R, Basri H, Sismadi P, Miller GB, Chulay JD, Fryauff DJ, Hoffman SL, Baird JK.

Clin Infect Dis. 2002 Nov 1;35(9):e92-5. Epub 2002 Oct 9.

PMID:
12384852
6.

A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.

Mavrogordato A, Lever AM.

J Infect. 2012 Sep;65(3):269-74. doi: 10.1016/j.jinf.2012.04.015. Epub 2012 May 16.

PMID:
22609735
7.

Atovaquone + proguanil: new preparation. Second-line antimalarial combination.

[No authors listed]

Prescrire Int. 2002 Oct;11(61):131-6.

PMID:
12378742
8.

[Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].

Blondé R, Naudin J, Bigirimana Z, Holvoet L, Fenneteau O, Vitoux C, Bourdon O, Angoulvant F, Lorrot M, D'Ortenzio E, Bourrillon A, Le Bras J, Matheron S, Faye A.

Arch Pediatr. 2008 Mar;15(3):245-52. doi: 10.1016/j.arcped.2007.10.018. Epub 2008 Mar 5. French.

PMID:
18321692
9.

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.

Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.

Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.

10.

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.

Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, Roskell NS, Hedgley C, De Boever EH, Miller GB; International Malarone Study Team.

Clin Infect Dis. 2004 Jun 15;38(12):1716-23. Epub 2004 May 27.

PMID:
15227617
11.

Problems in the therapy for imported malaria in the United States.

Singh K, Wester WC, Trenholme GM.

Arch Intern Med. 2003 Sep 22;163(17):2027-30.

PMID:
14504115
12.

Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD; Malarone International Study Team.

Clin Infect Dis. 2001 Oct 1;33(7):1015-21. Epub 2001 Sep 5.

PMID:
11528574
13.

Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.

DePetrillo JC, Singer C, Bergagnini IA, Kolakowski P, Edwards B, Smith MA.

J Travel Med. 2010 Jul-Aug;17(4):217-20. doi: 10.1111/j.1708-8305.2010.00426.x.

14.

Malaria--eight years of experience in a Tokyo metropolitan hospital.

Ohnishi K, Murata M.

Intern Med. 1996 Feb;35(2):111-4.

15.

Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand.

Looareesuwan S, Wilairatana P, Glanarongran R, Indravijit KA, Supeeranontha L, Chinnapha S, Scott TR, Chulay JD.

Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):637-40.

PMID:
10717754
16.

Atovaquone/proguanil for the prophylaxis and treatment of malaria.

Patel SN, Kain KC.

Expert Rev Anti Infect Ther. 2005 Dec;3(6):849-61. Review.

PMID:
16307498
17.

Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.

Am J Trop Med Hyg. 2007 Apr;76(4):655-8.

PMID:
17426165
19.

Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report.

Blossom DB, King CH, Armitage KB.

Am J Trop Med Hyg. 2005 Jul;73(1):188-90.

PMID:
16014856
20.

The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.

Petersen E.

J Travel Med. 2003 May;10 Suppl 1:S13-5; discussion S21.

Supplemental Content

Support Center